Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment of neurological and neuropsychiatric illnesses; taldefgrobep alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 3 clinical trial for the treatment of focal and generalized epilepsy, and major depressive disorder; BHV-2100 tha...
Sep 10, 2025, 3:39 PM EDT - 5 days ago
Sep 6, 2025, 10:03 AM EDT - 9 days ago
Aug 28, 2025, 6:55 PM EDT - 18 days ago
Aug 25, 2025, 8:00 AM EDT - 21 days ago
Aug 22, 2025, 10:05 AM EDT - 24 days ago
Aug 11, 2025, 7:00 AM EDT - 5 weeks ago
Aug 4, 2025, 8:45 AM EDT - 6 weeks ago
Jul 18, 2025, 12:06 PM EDT - 2 months ago
Jul 18, 2025, 12:00 PM EDT - 2 months ago
Jul 15, 2025, 10:46 AM EDT - 2 months ago
Jun 10, 2025, 2:00 PM EDT - 3 months ago
May 29, 2025, 7:01 AM EDT - 3 months ago
May 28, 2025, 3:00 PM EDT - 3 months ago
May 28, 2025, 7:30 AM EDT - 3 months ago
May 15, 2025, 1:22 PM EDT - 4 months ago
May 14, 2025, 6:43 PM EDT - 4 months ago
May 12, 2025, 4:05 PM EDT - 4 months ago
May 5, 2025, 8:00 AM EDT - 4 months ago
Apr 28, 2025, 7:30 AM EDT - 5 months ago
Apr 15, 2025, 9:10 AM EDT - 5 months ago
Apr 5, 2025, 9:00 AM EDT - 5 months ago